Anecdotal cases for CarTCell NF protocol

 

 

Patient ID

T.B.

A.G.

V.Ch.

L.B.

F.E.

Gender

Female

Female

Male

Male

Female

Date of birth

1945

1952

1947

1928

1978

Diagnosis

Breast cancer

Breast cancer

Lung cancer,

Non-operable form

Lung cancer, left.

 

Colon Cr.

Diagnosed in

1998

2002

2006

2005

2006

Clinical History:

Mastectomy, chemotherapy, radiotherapy,  Zometa, Xeloda, Tomoxifen.

Chemo stopped because of side effects.

Mastectomy, chemotherapy, radiotherapy.

Zometa, Arimidex (instead Tomoxifen)

Radiotherapy

Surgery, Tarceva (with side effects)

Surgery

Chemotherapy,

Radiotherapy

Condition before course

Metastatic process in the bones of pelvis and cranium. Metastases in left ribs (6, 7 left). Pain in spine. CA 27.29 = 176.3 U/ml (N<38.6).

Bone metastases. Pain in the bones. PET scan: The  abnormal bony glucose uptake in T8, T11, L1,Tip of right scapula or posterolateral right rib, left scapula. High level of CA 27.29.

Bone metastases. Interstitial opacities in both lungs.

Back and chest pain. Dry cough, fatigue, decreased energy.

Metastases in lung, right.
Mts in adrenal gland (mass 2x3 cm)

Multiple Mts  in lung the largest – 5 mm), in liver (14 mm)

CarTcell course

3 bottles  /day

3 bottles /day (2 month)

3 bottles  /day

3 bottles  /day

3 bottles  /day

Additional therapy

Zeloda (on regular basis).

Dietary supplements

Dietary supplements, on regular basis.

 

Only dietary supplements on regular basis.

Tarceva

(low side effects)

Avastin – only at the last month. (3 injections)corresponding

With abdominal pain

Condition after course

Pain in spine disappeared. Improvement of Quality of Life.

CA 27.29 = 43.0 U/ml (N<38.6).

No remarkable side effects on the chemo – Xeloda (previously she had a lot).

Stable condition.

PET scan: “There has been improvement in the abnormal bony uptake which was seen on the prior examination”. Abnormal uptake T8, T11, L1 has nearly complitly resolved, right scapula or posterolateral right rib has resolved, left scapula less intense uptake with pick 1.8( prior examination 6.8)

Improvement of Quality of Life.

CA 27.29 = 27.5 U/ml

Diminishing of the opacities area in lungs.

Quality of Life improvement.

Pain in the bones disappeared.

No fatigue, more energy, less cough.

CT-scan
resolution of Mts in lung and in adrenal gland.

Disappearance of hepatic lesion. Stable number of lung nodules. The largest nodles  1- 2 mm smaller. In size

Improvement of Quality of Life – more energy.

 

 

Copyright © 2015